Description
Retatrutide 20mg – Triple Agonist for Advanced Weight Loss & Metabolic Research
Retatrutide 20mg is a next-generation multi-receptor agonist designed to support substantial weight reduction and metabolic health optimization. By simultaneously activating GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors, Retatrutide offers a triple-action mechanism that helps regulate appetite, enhance insulin sensitivity, increase fat oxidation, and stabilize blood glucose levels.
This 20mg formulation is typically evaluated in advanced research protocols where a higher therapeutic threshold is being studied for its potential impact on obesity, insulin resistance, and energy balance.
Key Features:
-
20mg high-purity Retatrutide peptide
-
Triple agonist: GLP-1, GIP, and glucagon receptor activation
-
Promotes weight loss, appetite suppression, and fat metabolism
-
Enhances insulin sensitivity and glycemic control
-
Ideal for advanced metabolic and obesity-related research
⚠️ For Research Use Only. Not for Human Consumption.
This product is intended strictly for investigational and laboratory use. It is not approved for human use, medical treatment, or diagnostic purposes.